Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Gastroenterology

Demographic and Socioeconomic Influences on Helicobacter Pylori Gastritis and Its Pre-Neoplastic Lesions Amongst US Residents

Alimentary Pharmacology and Therapeutics

English

Editorial: Probiotics in Inflammatory Bowel Disease-Wrong Organisms, Wrong Disease, or Flawed Concepts?

Alimentary Pharmacology and Therapeutics

English

Editorial: Scoring Systems in Primary Biliary Cholangitis - Time to Make a Move

Alimentary Pharmacology and Therapeutics

English

Review Article: Transient Receptor Potential Channels as Possible Therapeutic Targets in Irritable Bowel Syndrome

Alimentary Pharmacology and Therapeutics

English

Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a

Alimentary Pharmacology and Therapeutics

English

Editorial: Suicide and IBD-a Call to Action

Alimentary Pharmacology and Therapeutics

English

Letter: Bias in Clinical Trials of the Symptomatic Effects of the Low FODMAP Diet for Irritable Bowel Syndrome-Getting the Facts Right. Authors' Reply

Alimentary Pharmacology and Therapeutics

English

Letter: Immunogenicity of Infliximab Originator vs. CT-P13 in IBD Patients

Alimentary Pharmacology and Therapeutics

English

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Alimentary Pharmacology and Therapeutics

English

Editorial: Genotype 3 HCV-who Still Needs Ribavirin in a Pan-Genotypic Era?

Alimentary Pharmacology and Therapeutics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Gastroenterology

Demographic and Socioeconomic Influences on Helicobacter Pylori Gastritis and Its Pre-Neoplastic Lesions Amongst US Residents

Editorial: Probiotics in Inflammatory Bowel Disease-Wrong Organisms, Wrong Disease, or Flawed Concepts?

Editorial: Scoring Systems in Primary Biliary Cholangitis - Time to Make a Move

Review Article: Transient Receptor Potential Channels as Possible Therapeutic Targets in Irritable Bowel Syndrome

Editorial: The Durability of Seroconversion of Hepatitis B E Antigen in the Treatment of Chronic Hepatitis B With PEG-interferon Alfa-2a

Editorial: Suicide and IBD-a Call to Action

Letter: Bias in Clinical Trials of the Symptomatic Effects of the Low FODMAP Diet for Irritable Bowel Syndrome-Getting the Facts Right. Authors' Reply

Letter: Immunogenicity of Infliximab Originator vs. CT-P13 in IBD Patients

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Editorial: Genotype 3 HCV-who Still Needs Ribavirin in a Pan-Genotypic Era?